+143.3%
MRNA vs ENB
-4.8%
+148.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.7% | -2.7% | -5.4% |
| 7D | -10.1% | -0.3% | -9.8% | -11.0% |
| 30D | +126.7% | -1.1% | +127.8% | +125.3% |
| 3M | +184.1% | -8.5% | +192.6% | +169.1% |
| 6M | +143.3% | -4.5% | +147.8% | +142.3% |
| All | +143.3% | -4.8% | +148.1% | +142.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling